24438483|t|Pre-treatment of bupivacaine-induced cardiovascular depression using different lipid formulations of propofol.
24438483|a|BACKGROUND: Pre-treatment with lipid emulsions has been shown to increase lethal doses of bupivacaine, and the lipid content of propofol may alleviate bupivacaine-induced cardiotoxicity. The aim of this study is to investigate the effects of propofol in intralipid or medialipid emulsions on bupivacaine-induced cardiotoxicity. METHODS: Rats were anaesthetised with ketamine and were given 0.5 mg/kg/min propofol in intralipid (Group P), propofol in medialipid (Group L), or saline (Group C) over 20 min. Thereafter, 2 mg/kg/min bupivacaine 0.5% was infused. We recorded time to first dysrhythmia occurrence, respective times to 25% and 50% reduction of the heart rate (HR) and mean arterial pressure, and time to asystole and total amount of bupivacaine consumption. Blood and tissue samples were collected following asystole. RESULTS: The time to first dysrhythmia occurrence, time to 25% and 50% reductions in HR, and time to asystole were longer in Group P than the other groups. The cumulative bupivacaine dose given at those time points was higher in Group P. Plasma bupivacaine levels were significantly lower in Group P than in Group C. Bupivacaine levels in the brain and heart were significantly lower in Group P and Group L than in Group C. CONCLUSION: We conclude that pre-treatment with propofol in intralipid, compared with propofol in medialipid or saline, delayed the onset of bupivacaine-induced cardiotoxic effects as well as reduced plasma bupivacaine levels. Further studies are needed to explore tissue bupivacaine levels of propofol in medialipid and adapt these results to clinical practice.
24438483	17	28	bupivacaine	ChemicalEntity	D002045
24438483	37	62	cardiovascular depression	DiseaseOrPhenotypicFeature	D002318
24438483	79	84	lipid	ChemicalEntity	D008055
24438483	101	109	propofol	ChemicalEntity	D015742
24438483	142	157	lipid emulsions	ChemicalEntity	D005217
24438483	201	212	bupivacaine	ChemicalEntity	D002045
24438483	222	227	lipid	ChemicalEntity	D008055
24438483	239	247	propofol	ChemicalEntity	D015742
24438483	262	273	bupivacaine	ChemicalEntity	D002045
24438483	282	296	cardiotoxicity	DiseaseOrPhenotypicFeature	D066126
24438483	353	361	propofol	ChemicalEntity	D015742
24438483	365	375	intralipid	ChemicalEntity	C545823
24438483	379	389	medialipid	ChemicalEntity	D008055
24438483	403	414	bupivacaine	ChemicalEntity	D002045
24438483	423	437	cardiotoxicity	DiseaseOrPhenotypicFeature	D066126
24438483	448	452	Rats	OrganismTaxon	10116
24438483	477	485	ketamine	ChemicalEntity	D007649
24438483	515	523	propofol	ChemicalEntity	D015742
24438483	527	537	intralipid	ChemicalEntity	C545823
24438483	549	557	propofol	ChemicalEntity	D015742
24438483	561	571	medialipid	ChemicalEntity	D008055
24438483	640	651	bupivacaine	ChemicalEntity	D002045
24438483	696	707	dysrhythmia	DiseaseOrPhenotypicFeature	D001145
24438483	825	833	asystole	DiseaseOrPhenotypicFeature	D006323
24438483	854	865	bupivacaine	ChemicalEntity	D002045
24438483	929	937	asystole	DiseaseOrPhenotypicFeature	D006323
24438483	966	977	dysrhythmia	DiseaseOrPhenotypicFeature	D001145
24438483	1040	1048	asystole	DiseaseOrPhenotypicFeature	D006323
24438483	1110	1121	bupivacaine	ChemicalEntity	D002045
24438483	1184	1195	bupivacaine	ChemicalEntity	D002045
24438483	1256	1267	Bupivacaine	ChemicalEntity	D002045
24438483	1411	1419	propofol	ChemicalEntity	D015742
24438483	1423	1433	intralipid	ChemicalEntity	C545823
24438483	1449	1457	propofol	ChemicalEntity	D015742
24438483	1461	1471	medialipid	ChemicalEntity	D008055
24438483	1504	1515	bupivacaine	ChemicalEntity	D002045
24438483	1524	1535	cardiotoxic	DiseaseOrPhenotypicFeature	D066126
24438483	1570	1581	bupivacaine	ChemicalEntity	D002045
24438483	1635	1646	bupivacaine	ChemicalEntity	D002045
24438483	1657	1665	propofol	ChemicalEntity	D015742
24438483	1669	1679	medialipid	ChemicalEntity	D008055
24438483	Association	D005217	D002045	No
24438483	Negative_Correlation	D008055	D066126	Novel
24438483	Negative_Correlation	D008055	D002045	No
24438483	Negative_Correlation	C545823	D066126	Novel
24438483	Comparison	C545823	D008055	Novel
24438483	Negative_Correlation	C545823	D002045	Novel
24438483	Negative_Correlation	D015742	D066126	Novel
24438483	Association	D015742	D008055	Novel
24438483	Association	D015742	C545823	Novel
24438483	Negative_Correlation	D015742	D002318	Novel
24438483	Negative_Correlation	D015742	D002045	Novel
24438483	Positive_Correlation	D002045	D066126	No
24438483	Positive_Correlation	D002045	D002318	No